In the last trading session, 1.31 million shares of the FibroGen Inc (NASDAQ:FGEN) were traded, and its beta was 0.89. Most recently the company’s share price was $1.15, and it changed around -$0.02 or -1.71% from the last close, which brings the market valuation of the company to $113.59M. FGEN currently trades at a discount to its 52-week high of $20.73, offering almost -1702.61% off that amount. The share price’s 52-week low was $0.33, which indicates that the current value has risen by an impressive 71.3% since then. We note from FibroGen Inc’s average daily trading volume that its 3-month average coming to 2.80 million.
FibroGen Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 4.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 2 recommended FGEN as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. FibroGen Inc is expected to report earnings per share of $The Generation Z ETF for the current quarter.
FibroGen Inc (NASDAQ:FGEN) trade information
Instantly FGEN has showed a red trend with a performance of -1.71% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 29.75% year-to-date, but still down -11.54% over the last five days. On the other hand, FibroGen Inc (NASDAQ:FGEN) is -51.27% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $28, which translates to bulls needing to increase their stock price by 95.89% from its current value. Analyst projections state that FGEN is forecast to be at a low of $28 and a high of $28.
FibroGen Inc (FGEN) estimates and forecasts
FibroGen Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 93.37 percent over the past six months and at a 59.18% annual growth rate that is well above the industry average of 10.20%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -23.23%.
FGEN Dividends
FibroGen Inc’s next quarterly earnings report is expected to be released around May 06 and May 10.
